Not exact matches
Immunotherapy differs from
more traditional cancer treatments, such as surgery (cutting malignant cells out
of the body), chemotherapy and radiation (poisoning the deadly mutants), and even the newer,
more precise molecular drugs that attempt to jam the protein signals that tell
tumor cells to keep dividing and conquering.
And using lower levels
of Yervoy in combination with Opdivo actually prompted
more tumor shrinkage, underscoring the fact that dosing is a critical and unpredictable factor for immunotherapies.
When Jedd Wolchok, a cancer doctor and immunologist leading a Yervoy trial at Memorial Sloan Kettering, examined a melanoma patient's scan 12 weeks after he'd received his course
of treatment, the results were utterly disappointing — just like those
of any other metastatic patient in the final throes
of the disease: The
tumors had gotten bigger, and there were
more of them.
Yet since 1985, there have been only four FDA - approved drugs to treat the
more than 120 different types
of brain
tumors, according to the National Brain
Tumor Society.
Patients in the trial had advanced NSCLC, and their
tumors tested positive for PD - L1 levels
of 50 % or
more.
As a cancer researcher, do you think the mechanisms
of tumor growth are somehow changing to come into line with your perceptions, or is it possible that the process
of our learning
more about DNA mutations and cell architecture and nutrient exchange and epigenetic effects make it possible for us to inch ever closer to understanding that which is already going on under our noses?
I told her that there was a suggestion
of a possible
tumor and wondered if anyone could give me
more details on the situation.
Surely, for a patient who can no longer assimilate food, N&H provides no benefit; similarly, some stomach cancer cases result in feeding the
tumor instead
of the patient; and there are those who are so fragile that almost any invasive insert causes
more problems than it relieves.
To Shiney: First
of all, the «knot» on the side
of the head
of your pastor's wife was
more than likely a cyst — not a
tumor.
But his sense
of humor Was
more like a
tumor And his political judgment was nil.
According to one study, however, cysteine supplementation with whey protein actually lowered levels
of glutathione in some
tumors, making them
more susceptible to chemotherapy.
Coapplication
of capsaicin with TPA to the dorsal surface
of either TRPV1 / WT or KO mice induced significantly
more and larger skin
tumors compared with TPA treatment alone (Table 1; Fig. 1A — C).
Topical application
of capsaicin on the dorsal skin
of 7,12 - dimetylbenz (a) anthracene — initiated and TPA - promoted TRPV1 wild - type (WT) and TRPV1 knockout (KO) mice induced
more and larger skin
tumors in TRPV1 / KO mice, suggesting a TRPV1 - independent mechanism.
The story is an allegory for the death
of Pirola's own father, John, who suffered for years through searing neuropathic pain as a result
of a brain stem
tumor, and over several years, underwent
more than 10 brain / skull - based surgeries.
The study indicated that even a small period
of breastfeeding reduces the risk
of these stubborn
tumors, which are
more common in younger women and generally have a poorer prognosis than other subtypes
of breast cancer.
The introduction
of infant formula to babies» diets changes the infants» gut microbiome, thus affecting the response
of the infant immune system to pathogens.47 - 51 A greater amount
of natural - killer cells, suggesting a
more mature immune system, have been found in breastfed infants than in formula - fed infants.52 In addition, pH level in the stomach
of breastfed children is better for the promotion
of the protein - lipid α - lactalbumin (termed HAMLET), which induces apoptosislike death in
tumor cells.51, 53
Former President Jimmy Carter said that his most recent brain scan showed no signs
of cancer,
more than three months after he began treatment for four melanoma
tumors.
After adjusting for age,
tumor location, and stage, researchers from Cleveland Clinic's Dermatology & Plastic Surgery Institute discovered that women diagnosed with malignant melanoma during their pregnancy or within one year
of giving birth were 5.1 - times as likely to die, 6.9 - times as likely to experience metastasis, and 9.2 - times
more likely to have a recurrence.
Triple negative patients usually have shorter survival time after diagnosis
of brain metastasis, suggesting that these
tumor cells adapt much
more readily once they've moved to the brain.
As researchers learn
more about genetic profile
of various cancers, other work is charging ahead to deliver personalized vaccines targeted to a patient's own
tumor cells
«This research represents a big step forward in understanding why some
tumors are
more aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member
of the David M. Rubenstein Center for Pancreatic Cancer Research at MSK, and corresponding author
of the companion study in Nature.
Even after initial purification
of the sample, liquid biopsies typically contain much
more nucleic acid from healthy cells than from
tumors.
While
more sensitive assays have enabled doctors to take smaller samples
of some types
of solid
tumors, oncologists have long dreamed
of avoiding traditional biopsies altogether.
More precise application
of immuno - therapies and the development
of new approaches requires knowing the detailed immune landscape
of individual patients and
tumors.
Many biomarkers are available for estimating
tumor mass, but a possibly
more important aspect
of a
tumor's pathology is how aggressive it is and how fast it is growing.
Among the advances that have already been made are linear accelerators that generate higher - energy radiation beams, and
more versatile patient tables that enable radiation doses to be delivered to the
tumor from a variety
of angles and directions.
Recent advances in the understanding
of cancer have led to
more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in
tumors to predict a patient's response to therapy.
Once they have consumed all the oxygen and nutrients in the original
tumor site, the cancer cells travel to other parts
of the body (metastasize) to find
more nourishment.
Overall, 34 percent
of patients showed an objective response, meaning that their
tumors shrank by
more than 30 percent, and did not re-grow.
«It was really surprizing to realize that oncogenic Pik3ca in basal cells induced the formation
of luminal tumours, while its expression in luminal cells gave rise to heterogeneous and
more aggressive
tumors including basal - like
tumors,» comments Alexandra Van Keymeulen, the first author
of the paper.
Many
more microchimeric cells are found in the blood
of healthy women compared to those with breast cancer, for example, suggesting that microchimeric cells can somehow prevent
tumor formation.
«However, the immense complexity
of tumors and their genomic aberrations will require sophisticated computer technologies for optimal interpretation, and patients need access to
more clinical trials and to targeted drugs.»
This additional information will help in the next steps
of the research, which involve
more detailed study
of the PD - 1 at different points in its pathway and with different viral or
tumor loads.
In the presence
of these drugs
tumors grow faster and develop
more extensive networks
of the blood vessels they rely on to feed their expansion — a process called angiogenesis, says Jonathan Moss, an anesthesiologist at the University
of Chicago (U.
of C.) Medical Center.
Working from
more than a dozen X-ray images to piece together a full image
of the
tumor and organs
of the body, Goitein had to make thousands
of calculations for each patient to figure out the angle, strength and penetration
of the beam.
For example, HPV - inactive
tumors were 17 times
more likely to contain disrupting TP53 gene mutations than HPV - active cervical cancers, rendering unnecessary the expression
of the HPV E6 oncogene.
Additionally, lung cancer patients who have high levels
of YAP1 in their
tumors are
more likely to have a poorer prognosis than patients with low levels
of YAP1.
Virtual - reality technology is giving surgeons the equivalent
of x-ray vision, helping them to remove
tumors more effectively, to minimize surgical wounds and to avoid damaging critical tissues
The identification
of the cancer cell
of origin has important clinical implications, as it enables doctors to detect malignancies earlier and predict
tumor behavior
more accurately.
Conventional radiation with photons gave way to intensity - modulated radiation therapy, or IMRT, in which
more precise beams
of photons could be moved dozens or hundreds
of times with varying intensities, attacking
tumors in three dimensions with safer high doses.
Conventional, high - dose chemotherapy treatments can cause the fibroblast cells surrounding
tumors to secrete proteins that promote the
tumors» recurrence in
more aggressive forms, researchers at Taipei Medical University and the National Institute
of Cancer Research in Taiwan and University
of California, San Francisco, have discovered.
«Just as normal cells with the same genome differentiate into many different cell types, a single
tumor characterized by specific genetic mutations can contain many different types
of cells — stem - like and
more differentiated cells — with the difference being rooted in their epigenetic information.
Looking to target a key pathway in order to interfere with the processes that lead to
tumor spread, a research team led by Irwin H. Gelman, Ph.D.,
of Roswell Park Cancer Institute (RPCI) has identified a new suppressor
of cancer metastasis that may point the way toward development
of more effective treatments for prostate cancers and other malignant solid
tumors.
Their analysis
of more than 4,000 individual
tumor cells, the largest effort to date in brain
tumors, finds three developmental categories
of cancer cells — one resembling neural stem cells and two characterized by sets
of genes indicting paths towards differentiation.
With that knowledge, they screened
more than four dozen monoclonal antibodies — unique agents that can stop cells from growing or forming
tumors and can be mass produced — before finding two that block
tumor creation in both types
of cancer.
«As well as finding
more effective treatments for advanced melanoma, we also need to stress the importance
of early diagnosis, detecting
tumors before they have a chance to spread.»
We found that the inflammation unfortunately gets hijacked by
tumor cells that are able to grow faster and penetrate deeper because the blood vessels in the brain are
more permeable than in any other part
of the body.
More light leads to a greater flow
of calcium, so the researchers are able to finely tune the calcium - dependent actions
of immune cells to fight against invading pathogens or
tumor cells.
Our specialty is accustomed to
more than its share
of depressing outcomes, from lives cut short by brain
tumors to minds devastated by head injury.
In past imaging studies, my colleagues and I noticed that cervical
tumors that took up a lot
of glucose prior to radiation treatment tended to be
more resistant to radiation therapy than other
tumors.